title: Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation.
abstract: The capacity of inflammatory cell-derived matrix metalloproteinases (MMPs) to cleave tissue factor pathway inhibitor (TFPI) and alter its activity was investigated. MMP-7 (matrilysin) rapidly cleaved TFPI to a major 35-kDa product. In contrast, MMP-1 (collagenase-1), MMP-9 (gelatinase B), and MMP-12 (macrophage elastase) cleaved TFPI into several fragments including the 35-kDa band. However, rates of cleavage were most rapid for MMP-7 and MMP-9. NH(2)-terminal amino acid sequencing revealed that MMP-12 cleaved TFPI at Lys(20)-Leu(21)(close to Kunitz I domain and producing a 35-kDa band), Arg(83)-Ile(84) (between Kunitz I and II domains), and Ser(174)-Thr(175) (between Kunitz II and III domains). MMP-7 and MMP-9 cleaved TFPI at Lys(20)-Leu(21) with additional COOH-terminal processing. These MMPs did not cleave tissue factor (TF), factor VII, and factor Xa. Proteolytic cleavage by MMP-1, MMP-7, MMP-9, and MMP-12 resulted in considerable loss of TFPI activity. These observations indicate specific cleavage of TFPI by MMPs, which broadens their substrate profile. Co-localization of MMPs, TF, and TFPI in atherosclerotic tissues suggests that release of MMPs from inflammatory cell leukocytes may effect TF-mediated coagulation.
authors.affiliation: Departments of Pediatrics, Medicine, and Cell Biology and Physiology, Washington University School of Medicine, St. Louis Children's Hospital and Barnes-Jewish Hospital, St. Louis, Missouri 63110, USA. belaaouaja@msnotes.wustl.edu
authors.forename: A A
authors.initials: AA
authors.lastname: Belaaouaj
authors.forename: A
authors.initials: A
authors.lastname: Li
authors.forename: T C
authors.initials: TC
authors.lastname: Wun
authors.forename: H G
authors.initials: HG
authors.lastname: Welgus
authors.forename: S D
authors.initials: SD
authors.lastname: Shapiro
mesh_terms: D001483:Base Sequence; D001777:Blood Coagulation; D017931:DNA Primers; D005167:Factor VII / Q000378:metabolism; D015951:Factor Xa / Q000378:metabolism; D006801:Humans; D006868:Hydrolysis; D007249:Inflammation / Q000378:metabolism / Q000503:physiopathology; D008074:Lipoproteins / Q000378:metabolism*; D020782:Matrix Metalloproteinases / Q000378:metabolism*; D011994:Recombinant Proteins / Q000378:metabolism; D013925:Thromboplastin / Q000378:metabolism
chemical_list: D017931:DNA Primers; D008074:Lipoproteins; D011994:Recombinant Proteins; C051928:lipoprotein-associated coagulation inhibitor; D005167:Factor VII; D013925:Thromboplastin; D015951:Factor Xa; D020782:Matrix Metalloproteinases